Zydus receives USFDA approval for Phase2(b)/3 trial of Saroglitazar
Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)
Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
A first for the Asian market, addressing the health spends needs of over 200 million households.
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
Carestream equipment is highly recommended for its imaging quality
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
Subscribe To Our Newsletter & Stay Updated